JINGXIN

Zhitong · Oct 31, 2025 at 03:18 AM

JINGXIN: Cumulative repurchase of 609 million yuan

Zhitong · Sep 3, 2025 at 05:05 AM

JINGXIN has repurchased 5.49% of its shares, costing 609 million yuan

Zhitong · Aug 26, 2025 at 06:57 AM

JINGXIN: Net profit in the first half of 2025 is 388 million yuan, a year-on-year decrease of 3.54%

Zhitong · Aug 14, 2025 at 10:59 PM

JINGXIN: As of the announcement date, a total of 290 million yuan of the raised funds for temporarily supplementing working capital has been fully returned to the special account for raised funds, and the usage period has not exceeded 12 months

Zhitong · Aug 11, 2025 at 08:36 PM

The traditional Chinese medicine concept continues to strengthen, with Layn hitting the daily limit, and companies such as Zhongsheng Pharmaceutical, Kanion Pharmaceutical, JINGXIN, Zhendong Pharmacy, CONBA, and Chase Sun also rising

Zhitong · Aug 8, 2025 at 04:11 AM

JINGXIN: Currently, it has not yet involved in the field of brain-machine interface technology